• Mashup Score: 4

    The first Phase 3 randomised clinical tria l of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and safety of a norovirus vaccine called mRNA-1403. There are currently no licensed norovirus vaccines in use anywhere in the world. The Phase 3 trial will take place at 39 sites across the country. This includes 27 NHS primary and secondary care sites. It aims to recruit 2,500 participants in the UK between

    Tweet Tweets with this article
    • Read more about the background to this study here 👇 https://t.co/MqPinATDRl